medigraphic.com
Academia Mexicana de Neurología, A.C.

2019, Number 2

<< Back Next >>

Rev Mex Neuroci 2019; 20 (2)

Clinical guideline: status epilepticus in children and adults

Olmos-López A, Ibarra-Aguilar J, Cornelio-Nieto JO, Ocaña-Hernández LA, Márquez-Amaya MA, Luna-López N, Reséndiz-Aparicio JC, Rodríguez-Leyva I

Language: English
References: 18
Page: 110-115
PDF size: 103.28 Kb.


ABSTRACT

A generalized epileptic seizure lasting 5 or more minutes, or the presence of two or more seizures without recovering consciousness within 30 min, or a focal seizure that persists for >10 min, or with altered consciousness lasting for 60 min or more is called status epilepticus (SE). It can be classified into generalized and focal and motor and non-motor. Its etiology may or may not be recognized. The electroencephalographic pattern shows focal or generalized persistent epileptic activity. It is a dangerous situation, which requires algorithmic management from the time it is detected in the emergency room and if required, in intensive care. In-hospital management would include the initial ABCDE, hypertonic glucose solution, and thiamin; if hypoglycemia was detected. Lorazepam (midazolam [MDZ] or diazepam) to stop seizures, followed by phenytoin, valproate, or levetiracetam in impregnation and maintenance. If the SE persists for more than an hour, the patient will be admitted to an intensive care unit with intubation and continuous administration of MDZ, propofol or thiopental with continuous monitoring. If it does not yield with two drugs, it is called refractory epileptic status, and if it continues for 24 h or more, it is recognized as super-refractory. A third of patients die.


REFERENCES

  1. Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus report of the ILAE task force on classification of status epilepticus. Epilepsia 2015;56:1515-23.

  2. Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010;17:348-55.

  3. Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3-23.

  4. Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus. Eur J Neurol. 2006;13:445-50.

  5. Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society. Epilepsy Curr. 2016;16:48-61.

  6. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans affairs status epilepticus cooperative study group. N Engl J Med. 1998;339:792-8.

  7. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345:631-7.

  8. Mayer SA, Claassen J, Lokin J, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59:205-10.

  9. Bleck TP. Management approaches to prolonged seizures and status epilepticus. Epilepsia. 1999;40, s59-s63.

  10. Yasiry Z and Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure. 2014;23(3):167-74.

  11. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med. 1998; 338:970-6.

  12. Appleton R, Choonara I, Martland T, et al. The treatment of convulsive status epilepticus in children. Arch Dis Childhood. 2000;83:415-9.

  13. Kinney MO, Craig JJ, Kaplan PW. Non-convulsive status epilepticus: mimics and chameleons. Pract Neurol. 2018;18:291-305.

  14. Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993;43:483-8.

  15. Young GB, Jordan KG, Doig GS. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology. 1996;47: 83-9.

  16. Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry. 2005;76:534-9.

  17. Holtkamp M, Othman J, Buchheim K, et al. A “malignant” variant of status epilepticus. Arch Neurol. 2005;62:1428-31.

  18. Vasquez A, Farias-Moeller R, Tatum W. Pediatric refractory and super-refractory status epilepticus. Seizure. 2018:S1059-311.




2020     |     www.medigraphic.com